FDA Chides Akrimax Over Weight-Loss Product Promos
Akrimax Pharmaceuticals LLC published online promotions of weight loss drug Suprenza that failed to disclose any side effects and vastly overstated health benefits, according to a U.S. Food and Drug Administration...To view the full article, register now.
Already a subscriber? Click here to view full article